Quantum Genomics (Quantum Genomics) Pre-Tax Income : $-32.26 Mil (TTM As of Dec. 2022)

View and export this data going back to 2017. Start your Free Trial

What is Quantum Genomics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Quantum Genomics's pretax income for the six months ended in Dec. 2022 was $-19.82 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2022 was $-32.26 Mil. Quantum Genomics's pretax margin was 6,415.53%.

Quantum Genomics Pre-Tax Income Historical Data

The historical data trend for Quantum Genomics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum Genomics Pre-Tax Income Chart

Quantum Genomics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Pre-Tax Income

Get a 7-Day Free Trial

-15.35

-11.94

-16.87

-21.68

-32.29

Quantum Genomics Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Pre-Tax Income	Get a 7-Day Free Trial															-9.62	-7.64	-14.51	-12.44	-19.82

Competitive Comparison of Quantum Genomics's Pre-Tax Income

For the Biotechnology subindustry, Quantum Genomics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Quantum Genomics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quantum Genomics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Quantum Genomics's Pre-Tax Income falls into.

Quantum Genomics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Quantum Genomics's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-31.868	+	0	+	-0.019	+	0	+	-0.402
	=	-32.29

Quantum Genomics's Pretax Income for the quarter that ended in Dec. 2022 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-19.416	+	0	+	0.013	+	0	+	-0.421
	=	-19.82

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-32.26 Mil.

Quantum Genomics (OTCPK:QNNTF) Pre-Tax Income Explanation

Quantum Genomics's Pretax Margin for the quarter that ended in Dec. 2022 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-19.824	/	-0.309
	=	6,415.53%

Quantum Genomics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Quantum Genomics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Quantum Genomics (Quantum Genomics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum Genomics (OTCPK:QNNTF) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

ALQGC:France 2QG:Germany

Address

33, Rue Marbeuf, Paris, FRA, 75008

Website

https://quantum-genomics.com

Quantum Genomics is a biopharmaceutical company engaged in developing new products for unmet needs in the field of cardiovascular diseases, high blood pressure, and heart failure. The company products include firibastat, QGC006, QGC011, and others.